SO
VBIV

STRS Ohio’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

STRS Ohio’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-210
Closed -$22K – 2199
2018
Q1 		$22K Hold
210
– – ﹤0.01% 1816
2017
Q4 		$26K Hold
210
– – ﹤0.01% 1803
2017
Q3 		$24K Hold
210
– – ﹤0.01% 1860
2017
Q2 		$27K Buy
+210
New +$28.3K ﹤0.01% 1867

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

STRS Ohio's VBIV Position: Q2 2018 in Review

STRS Ohio sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2018, closing a stake of 210 shares — an estimated $22K sold.

STRS Ohio first reported a position in VBIV in Q2 2017 and held it in 4 quarters. The position peaked at $27K in Q2 2017. 48 funds tracked by Wall St. Rank hold VBIV as of Q2 2018.

  • STRS Ohio reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2018 after selling out during the quarter.
  • STRS Ohio sold 210 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2018, an estimated $22K.
  • STRS Ohio first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2017 and held it in 4 quarters.
  • STRS Ohio's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $27K in Q2 2017.
  • 48 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2018.

Based on STRS Ohio's 13F filing for Q2 2018, filed 6 Aug 2018.